Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Medivive vs Wellorithm

Medivive
Graded #343

Higher grade

vs+10.899999999999999
Wellorithm
Graded #486

Lower grade

The verdict

Medivive takes it — 59.4/100 to 48.5/100.

Medivive grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Medivive is a US telehealth service offering compounded semaglutide and tirzepatide for weight loss, filled through a licensed pharmacy, with providers licensed in all 50 states and no insurance required.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMedivive +40
70
30
Dose & formulationWellorithm +52
40
92
Clinical oversightMedivive +35
63
28
Labs & monitoringMedivive +24
64
40
FulfillmentWellorithm +1
61
62
Contract termsMedivive +10
55
45
Medivive · left barWellorithm · right bar

The numbers

MetricMediviveWellorithm
WeighScore59.4/10048.5/100
GradeCC
Scorecard rank#343#486
SemaglutideNot disclosedPricing not published
TirzepatideNot disclosedPricing not published
CoverageCoverage not published49 states (not Louisiana)
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Medivive

Graded #343 · C

Strengths

  • Compounded semaglutide and tirzepatide with providers licensed in all 50 states
  • No insurance required; one-stop for GLP-1 plus TRT, NAD+ and longevity care
  • Medication filled through a licensed pharmacy

Where it loses points

  • Monthly pricing not published; disclosed only after an AI intake
  • No legal entity or named pharmacy disclosed
  • Service states are not individually listed
Wellorithm

Graded #486 · C

Strengths

  • Both molecules in BOTH routes — compounded semaglutide and tirzepatide as injections and as oral dissolving tablets
  • Four branded pens on the same account: Mounjaro, Ozempic, Wegovy and Zepbound
  • Sermorelin offered alongside the GLP-1 line
  • 24/7 phone support on a published number

Where it loses points

  • No price appears anywhere on the public site — /pricing 404s and every product CTA leads to a 2-minute intake quiz, so no cost can be compared before signing up
  • The site contradicts itself on coverage: the homepage says "Serving All 50 States" while its own FAQ says 49 states and excludes Louisiana
  • The four clinicians presented as "board-certified obesity specialists" are listed as Cardiac Surgery, Pediatric Clinic, Gynecology and Cardiac Surgery — none in obesity medicine
  • "100% Customer Satisfaction" is stated as a headline fact and is not a substantiable claim

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard